Deallus
Deallus is a London-headquartered global life sciences consultancy, founded in 2005, delivering competitive intelligence, strategy, and wargaming workshop services to pharmaceutical, biotech, and med-tech clients across six offices. Acquired by GlobalData in December 2024.
- Company typePrivate
- Founded2005
- HeadquartersLondon, United Kingdom
- Headcount51–100
- GTM typeB2B
- OfferingServices
What Deallus does
Deallus is a London-headquartered global life sciences management consultancy founded in 2005, providing competitive intelligence and strategic advisory services to pharmaceutical, biotech, and med-tech clients. Its core delivery rests on three pillars: the Deallus Landscape Analyzer (an AI-assisted tool that rapidly builds competitive market landscapes), the Deallus Workshops franchise built around Competitive Simulation / Wargaming (which the company states accounts for ~85% of its workshop volume), and a portfolio of modular consulting services spanning therapy-area strategy, brand strategy, brand planning, brand positioning, product launch, competitive benchmarking, competitive deep dives, pricing and reimbursement, scenario planning, and CI best-practice advisory.
Deallus positions itself as an "extension of internal teams" for clients, leveraging a team of "commercial scientists" to deliver peer-to-peer partnerships with shared understanding of how science intersects with commercial realities. The firm operates six offices across London (HQ), New York, Los Angeles, Tokyo, Shanghai, and Gurugram, supporting 25+ languages and serving global pharma majors, emerging biopharma, and med-tech clients with deep specialization in neuroscience, oncology, rare diseases, and vaccines. Distribution is direct enterprise field sales; engagements are project-based with multi-year, multi-project client relationships. Underlying technology combines primary research methodologies with the AI-powered Landscape Analyzer and proprietary workshop playbooks; the firm is GDPR and UK Data Protection Act 2018 compliant.
Monetization is via bespoke consulting engagements priced on a quote basis (no public rate card), with revenue not disclosed. On December 31, 2024, Deallus was acquired by GlobalData Plc from private equity firm Archimed and now operates as a subsidiary within GlobalData's data and analytics platform, while continuing to operate under the Deallus brand.
Deallus firmographics
Firmographics- Name
- Deallus
- Legal name
- Deallus Consulting Limited
- Website
- https://deallus.com
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Deallus is a London-headquartered global life sciences consultancy, founded in 2005, delivering competitive intelligence, strategy, and wargaming workshop services to pharmaceutical, biotech, and med-tech clients across six offices. Acquired by GlobalData in December 2024.
- Ownership category
- akta.pro rank
Where Deallus is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices6 records
Markets served
Deallus business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Strategic Intelligence Consulting Services: Project-based consulting engagements providing competitive intelligence, strategic analysis, and advisory services to pharmaceutical, biotech, and med-tech companies. Services include market landscaping, competitive deep dives, brand strategy, therapy area strategy, and workshop facilitation. The company operates as a global life science consultancy with bespoke solutions tailored to client needs.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
Deallus product offering
Product offeringCore offering
Deallus is a global life sciences management consultancy that delivers strategic intelligence and competitive insight services to pharmaceutical, biotech, and med-tech companies. Its core offerings are the Deallus Landscape Analyser (an AI-enabled market landscape monitoring tool), Deallus Workshops (competitive simulation and wargaming sessions), and Therapy Area, Brand and Early Commercial Strategy services covering brand planning, positioning, launch support, benchmarking, threat analysis, scenario planning, and pricing and reimbursement advisory.
Product overview
Deallus is a global life science consultancy with heritage in Competitive Intelligence, providing a portfolio of strategic intelligence services to pharmaceutical, biotech, and med-tech companies. The core offerings include the Deallus Landscape Analyser (an AI-powered market analysis tool), Deallus Workshops (including Competitive Simulation/Wargaming workshops), and Therapy Area, Brand and Early Commercial Strategy services. These are supported by modular service components covering Brand Strategy Development, Brand Planning, Brand Positioning, Product Launch Services, Competitive Benchmarking, Competitive Deep Dives, Commercial Competitive Analysis, Competitor Threat Analysis, Conference Coverage, Scenario Planning & War Gaming, C.I. Best Practice Advisory, and Pricing & Reimbursement consulting. The company operates as a consultancy rather than a software product company, delivering tailored competitive intelligence solutions through primary research, market landscaping, workshops, and forecasting methodologies.
Differentiator
Problem solved
Functional benefit
Products and services
- Deallus Landscape Analyser AI-enabled market landscape monitoring platform that uses knowledge retrieval capabilities to continuously track therapy areas, competitors, and market developments for life sciences clients.
- Deallus Workshops Competitive simulation and wargaming sessions that bring client teams together with Deallus consultants to pressure-test strategy assumptions, rehearse competitor responses, and align cross-functional teams.
- Therapy Area, Brand and Early Commercial Strategy Portfolio of strategic consulting services for life sciences clients covering brand strategy development, brand planning, brand positioning, product launch services, competitive benchmarking, competitive deep dives, commercial competitive analysis, competitor threat analysis, conference coverage, scenario planning and war gaming, CI best-practice advisory, and pricing and reimbursement.
Companies that use Deallus
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Deallus technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature3 records
Deallus partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights5 records
Deallus competitors and assessment
Company assessmentDirect peers
- Trinity Partners: Strategic consulting firm dedicated to life sciences, providing commercial strategy, competitive insights and brand planning to pharma and biotech clients. Directly comparable on customer segment and service portfolio.
- ZS Associates: Global management consulting and technology firm with a deeply established pharma and biotech commercial strategy practice. Highly comparable to Deallus given overlapping focus on life sciences commercial strategy, brand planning, and competitive insights for global pharma clients.
- Health Advances: Specialist strategy consulting firm focused exclusively on healthcare and life sciences, covering commercial strategy, portfolio planning and competitive positioning. Closely comparable to Deallus on vertical specialization and pharma client mix.
- ClearView Healthcare Partners: Life sciences-focused strategy consulting firm serving pharmaceutical, biotech and med-tech clients on commercial strategy and competitive positioning. Directly comparable to Deallus on customer segment and service offering overlap.
- Prescient Healthcare Group: Specialist life-sciences strategy and competitive intelligence firm serving pharma and biotech. Closely comparable to Deallus on niche focus, therapy-area expertise, and competitive intelligence delivery model.
- Charles River Associates: Global consulting firm with a dedicated Life Sciences practice providing strategic and commercial advice to pharma, biotech and med-tech. Comparable on customer base, therapeutic-area expertise, and project-based strategic intelligence delivery.
Broad incumbents
- L.E.K. Consulting: Global strategy consultancy with one of the most established life sciences practices, covering commercial strategy, brand planning and competitive analysis for pharma and biotech — a broader incumbent competing for the same enterprise pharma wallet.
- McKinsey & Company (Pharma & Medical Products Practice): Global management consulting leader with a large, established pharma and medical products practice. Competes with Deallus for top-pharma strategic advisory work, though at a much broader scale and across a wider scope of engagements.
- IQVIA: Global leader in life sciences data, analytics and consulting with deep relationships across top pharma. A broad incumbent whose consulting arm competes with Deallus for pharma strategic intelligence engagements, particularly given the data + advisory bundle.
- Boston Consulting Group (Healthcare Practice): Top-tier global strategy consultancy with a dedicated healthcare and life sciences practice. Competes with Deallus for enterprise pharma strategic engagements, particularly in commercial strategy and competitive positioning workstreams.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Deallus social profiles
Digital presenceDeallus compliance and trust
Trust signalCompliance2 records
Deallus financial estimates
Financial estimateRevenue estimate
Valuation estimate
Deallus leadership team
Management profileNumber of profiles
Profiles6 records
Deallus funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Deallus M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Deallus
What does Deallus do?
Deallus is a global life sciences management consultancy that delivers strategic intelligence and competitive insight services to pharmaceutical, biotech, and med-tech companies. Its core offerings are the Deallus Landscape Analyser (an AI-enabled market landscape monitoring tool), Deallus Workshops (competitive simulation and wargaming sessions), and Therapy Area, Brand and Early Commercial Strategy services covering brand planning, positioning, launch support, benchmarking, threat analysis, scenario planning, and pricing and reimbursement advisory.
Is Deallus a public or private company?
Deallus is a private company. It is classified as corporate owned and is currently operating.
When was Deallus founded?
Deallus was founded in 2005. It employs 51 to 100 people.
Where is Deallus based?
Deallus is headquartered in London, United Kingdom, in the Europe region.
How does Deallus make money?
One revenue line is on record: strategic Intelligence Consulting Services.
Who are Deallus's main competitors?
Direct peers on record are Trinity Partners, ZS Associates, Health Advances, ClearView Healthcare Partners, Prescient Healthcare Group and Charles River Associates. Broad incumbents are L.E.K. Consulting, McKinsey & Company (Pharma & Medical Products Practice), IQVIA and Boston Consulting Group (Healthcare Practice).
Does Deallus have an API?
No public API is recorded for Deallus.